Back
Neurocrine Biosciences Vs. Bruker Industry Stock Comparison
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
122.88
Seasonality Move:
17.44%
Sell
28
BRKR
Bruker
Last Price:
54.51
Seasonality Move:
5.54%
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $125.51. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Bruker (BRKR)
is a Sell
Is Bruker a Buy, Sell or Hold?
- The current Bruker [BRKR] share price is $55.95. The Score for BRKR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- BRKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $125.51
The current trend is moderately bullish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.
BRKR Stock Price Chart
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.09 | Buy |
| Relative Strength Index (14 RSI): | 59.96 | Buy |
| Chaikin Money Flow: | -805588 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.9 - 123.94) | Buy |
| Bollinger Bands (100): | (117.3 - 144.96) | Sell |
BRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.8 | Sell |
| Relative Strength Index (14 RSI): | 36.78 | Sell |
| Chaikin Money Flow: | 83226 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.36 - 62.54) | Sell |
| Bollinger Bands (100): | (60.38 - 66.72) | Sell |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.6 | Buy |
| 20-day SMA: | 120.62 | Buy |
| 50-day SMA: | 118.6 | Buy |
| 200-day SMA: | 134.12 | Sell |
| 8-day EMA: | 124.66 | Buy |
| 20-day EMA: | 121.83 | Buy |
| 50-day EMA: | 122.69 | Buy |
| 200-day EMA: | 128.36 | Sell |
BRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.31 | Sell |
| 20-day SMA: | 58.97 | Sell |
| 50-day SMA: | 63.15 | Sell |
| 200-day SMA: | 71.62 | Sell |
| 8-day EMA: | 57.59 | Sell |
| 20-day EMA: | 59.29 | Sell |
| 50-day EMA: | 61.86 | Sell |
| 200-day EMA: | 67.3 | Sell |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $1.13 per share.
Bruker Earnings Growth & BRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.37 per share.
Neurocrine Biosciences Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bruker Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||